Validation of the Virga GFR equation in a renal transplant population

Ahmed Zahran1, Mohammad Akhtar Hossain, Mahmoud Abd Elaziz Kora

  • 1Internal Medicine Department, Menoufiya University Hospital, Menoufiya University, Menoufiya, Egypt.

Insights

The Virga equation shows promise for estimating glomerular filtration rate (GFR) in renal transplant patients, outperforming the Cockcroft-Gault equation. However, the MDRD-IDMS equation remains superior for moderate kidney failure, while Virga excels in mild cases.

Area of Science:

  • Nephrology
  • Renal Physiology
  • Medical Diagnostics

Background:

  • The Virga equation was previously shown to outperform Cockcroft-Gault (C-G) and MDRD-IDMS formulas for estimating glomerular filtration rate (GFR) in chronic kidney disease (CKD) patients.
  • Validating new GFR estimation equations is crucial for accurate patient management.

Purpose of the Study:

  • To validate the performance of the Virga equation in estimating GFR among 103 renal transplant patients.
  • To compare the accuracy of the Virga equation against established formulas like MDRD-IDMS and C-G in this specific population.

Main Methods:

  • Inulin clearance was used as the reference standard for GFR measurement.
  • The Virga, MDRD-IDMS, and C-G equations were evaluated based on error, accuracy, relative accuracy, precision, scatter, and coefficient of variance.
  • Statistical comparisons were performed on the overall patient cohort and specific subgroups (e.g., CKD stages).

Main Results:

  • The Virga equation demonstrated better performance than the C-G equation across all patient groups.
  • The MDRD-IDMS equation showed superior accuracy compared to the Virga equation in patients with moderate kidney failure (CKD stage 3T) and in males.
  • The Virga equation was superior to MDRD-IDMS in patients with mild kidney failure (CKD stage 2T).

Conclusions:

  • The choice of GFR estimation equation in renal transplant patients depends on the stage of kidney function.
  • MDRD-IDMS is recommended for moderate kidney failure, while the Virga equation is more accurate for mild kidney failure.
  • Estimating GFR using MDRD-IDMS is not advised for patients with normal renal function due to potential underestimation.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...